title: Piracetam in the treatment of myoclonus: an overview.
abstract: Myoclonus is a rare, but disabling symptom, occurring in a number of diseases of different origin. Aetiological and neurophysiological classifications, as well as the current treatment in myoclonus are discussed. An overview of the treatment of myoclonus with piracetam in 62 case reports, 3 open trials and 2 doubleblind trials, covering 171 patients is reported.
authors.affiliation: UCB Pharma, Marketing and Development International, Chemin du Foriest, Braine-l'Alleud, Belgium.
authors.forename: B
authors.initials: B
authors.lastname: Van Vleymen
authors.forename: M
authors.initials: M
authors.lastname: Van Zandijcke
mesh_terms: D000203:Activities of Daily Living; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D009207:Myoclonus / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use*
chemical_list: D018696:Neuroprotective Agents; D010889:Piracetam